GlassScriptPhysician profile
Maureen Grady
NPI 1306496872
$14,139.75
in general payments reported to CMS, 2019-2025
51 companies · $130 in 2025
The $130 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,356 · 2022: $4,496 · 2023: $3,407 · 2024: $1,751 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,255 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,254.90 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $3,202.55 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,294.64 | 2021-2024 | Mounjaro, Zepbound, Humulin |
| Astrazeneca Pharmaceuticals LP | $1,195.56 | 2021-2024 | Farxiga, Airsupra |
| Dexcom, INC. | $1,068.76 | 2021-2024 | Dexcom G6 Transmitter, Dexcom G7 Gss (161) |
| Sanofi-Aventis U.S. LLC | $682.49 | 2021-2024 | |
| Abbvie INC. | $582.45 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $507.28 | 2021-2024 | |
| Tandem Diabetes Care, INC. | $490.98 | 2021-2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Merck Sharp & Dohme LLC | $456.98 | 2021-2024 | Steglatro, Gardasil 9, Gardasil |
| Amgen INC. | $444.86 | 2021-2025 | Repatha, Evenity, Prolia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $402.02 | 2021-2024 | Jardiance, Tradjenta, Synjardy |
| Cequr Corporation | $387.71 | 2021-2025 | Cequr Simplicity |
| Amarin Pharma, INC. | $375.69 | 2021-2022 | |
| Corcept Therapeutics | $325.93 | 2021-2023 | Korlym |
| Pfizer INC. | $298.19 | 2021-2025 |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $247.78 | 2021-2024 | Unithroid |
| Xeris Pharmaceuticals, INC. | $221.38 | 2021-2024 | Gvoke Hypopen, Recorlev |
| Antares Pharma, INC. | $221.24 | 2021-2022 | |
| Horizon Therapeutics Plc | $208.03 | 2022-2023 | Tepezza |
| Insulet Corporation | $156.50 | 2021-2023 | Omnipod |
| Tolmar Pharmaceuticals, INC. | $137.53 | 2021-2022 | |
| Radius Health, INC. | $135.64 | 2021-2024 | Tymlos |
| Astellas Pharma US INC | $121.63 | 2024 | Veozah |
| Arbor Pharmaceuticals, INC. | $105.18 | 2021-2022 | |
| Lundbeck LLC | $78.31 | 2023-2024 | Rexulti |
| Azurity Pharmaceuticals, INC. | $76.25 | 2023 | Triptodur |
| Novartis Pharmaceuticals Corporation | $58.82 | 2022-2024 | |
| Ibsa Pharma INC. | $56.33 | 2021-2023 | Tirosint, Licart |
| Recordati_rare_diseases_inc. | $50.85 | 2021-2023 | Isturisa, Signifor Lar |
| Otsuka America Pharmaceutical, INC. | $49.82 | 2024 | Rexulti |
| Glaxosmithkline, LLC. | $46.47 | 2023 | Arexvy, Shingrix |
| Zealand Pharma US, INC. | $46.17 | 2021-2022 | |
| Ascendis Pharma Endocrinology INC | $36.72 | 2022 | |
| Halozyme INC | $36.56 | 2023 | |
| Esperion Therapeutics, INC. | $36.34 | 2021 | |
| Exact Sciences Corporation | $30.74 | 2023-2024 | Cologuard Collection Kit |
| Tolmar, INC. | $24.89 | 2023 | |
| Medtronic, INC. | $23.94 | 2024 | Inpen Smart Insulin Delivery System |
| Ipsen Biopharmaceuticals, INC | $22.68 | 2022 | |
| Daiichi Sankyo INC. | $19.80 | 2024 | Injectafer |
| Hologic Sales and Service, LLC | $18.91 | 2023 | Thinprep 2000 Processor, Aptima |
| Beta Bionics, INC. | $18.60 | 2023 | Ilet Bionic Pancreas |
| Mylan Specialty L.P. | $16.77 | 2024 | Yupelri |
| Endo Pharmaceuticals INC. | $16.64 | 2021 | |
| Lifescan, INC. | $16.52 | 2021 | |
| Eisai INC. | $16.28 | 2024 | |
| Eusa Pharma (US) LLC | $15.89 | 2022 | |
| Biomarin Pharmaceutical INC. | $15.67 | 2021 | |
| Amryt Pharma Holdings LTD | $15.06 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $11.96 | 2021 | |
| Organogenesis INC. | $11.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maureen Grady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.